1.  5
    A Failure in Solidarity: Ethical Challenges in the Development and Implementation of New Tuberculosis Technologies.Ana Komparic, Angus Dawson, Renaud F. Boulanger, Ross E. G. Upshur & Diego S. Silva - 2019 - Bioethics 33 (5):557-567.
    Direct download (5 more)  
    Export citation  
    Bookmark   1 citation  
  2.  23
    The Ethics of Introducing GMOs Into Sub‐Saharan Africa: Considerations From the Sub‐Saharan African Theory of Ubuntu.Ana Komparic - 2015 - Bioethics 29 (9):604-612.
    A growing number of countries in sub-Saharan Africa are considering legalizing the growth of genetically modified organisms. Furthermore, several projects are underway to develop transgenic crops tailored to the region. Given the contentious nature of GMOs and prevalent anti-GMO sentiments in Africa, a robust ethical analysis examining the concerns arising from the development, adoption, and regulation of GMOs in sub-Saharan Africa is warranted. To date, ethical analyses of GMOs in the global context have drawn predominantly on Western philosophy, dealing with (...)
    Direct download (4 more)  
    Export citation  
  3.  12
    An Ethical Justification for Expanding the Notion of Effectiveness in Vaccine Post-Market Monitoring: Insights From the HPV Vaccine in Canada.Ana Komparic, Maxwell J. Smith & Alison Thompson - 2016 - Public Health Ethics 9 (1):78-91.
    Health regulators must carefully monitor the real-world safety and effectiveness of marketed vaccines through post-market monitoring in order to protect the public’s health and promote those vaccines that best achieve public health goals. Yet, despite the fact that vaccines used in collective immunization programmes should be assessed in the context of a public health response, post-market effectiveness monitoring is often limited to assessing immunogenicity or limited programmatic features, rather than assessing effectiveness across populations. We argue that post-market monitoring ought to (...)
    Direct download (6 more)  
    Export citation